Why is it the right time to fund neuroendocrine tumor research?

It is the right time to fund neuroendocrine tumor research because the new genetic research paradigm has made it possible to discover a cure.

We live in a tremendously exciting time for cancer research.  The completion of the Human Genome Project (HGP) in 2003 marked a watershed in cancer research because it enabled scientists to study cancer at the genetic level and develop novel, targeted therapies.  The HGP was a thirteen-year effort coordinated by the National Institutes of Health and Department of Energy.  Its goals were to identify all the approximately 20,000-25,000 genes in human DNA, determine the sequences of the 3 billion chemical base pairs that make up human DNA, store this information in databases, improve the tools for data analysis, and transfer related technologies to the private sector.

Since the HGP's completion, the rapid emergence of high-powered computers, sophisticated software, and advanced tools for genetic analysis have accelerated the pace of cancer research.  The Caring for Carcinoid Foundation is fully harnessing these exciting scientific developments by funding cutting-edge, genetically based research to discover a cure for neuroendocrine tumors.